Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
87 studies found for:    "Sjogren's Syndrome"
Show Display Options
Rank Status Study
21 Completed Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
22 Recruiting PD of VAY736 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: VAY736;   Drug: Placebo
23 Recruiting Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CFZ533 active;   Drug: CFZ533 placebo
24 Completed A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome
Conditions: Dry Mouth Associated With Sjogren's Syndrome;   Xerostomia
Interventions: Drug: Placebo;   Drug: 552-02
25 Recruiting Salivary Biomarkers for Sjögren's Syndrome Detection
Condition: Sjögren's Syndrome
Intervention:
26 Completed Rituximab Treatment in Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: rituximab (anti-CD20)
27 Active, not recruiting Baminercept in Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Biological: Baminercept;   Other: Placebo
28 Completed Anti-CD20 Antibody Therapy for Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Rituximab
29 Completed Exploratory Study for Dry Mouth in Patients With Sjögren’s Syndrome
Conditions: Xerostomia;   Sjogren's Syndrome
Intervention: Drug: Rebamipide
30 Enrolling by invitation Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome
Condition: Primary Sjogren's Syndrome
Intervention:
31 Completed Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome
Conditions: Primary Sjogren's Syndrome;   Xerostomia;   Keratoconjunctivitis Sicca;   Fatigue
Interventions: Drug: MabThera (rituximab);   Drug: Rituximab, Mabthera
32 Recruiting Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
Condition: Primary Sjögren's Syndrome (pSS)
Interventions: Drug: Tocilizumab;   Drug: Placebo
33 Completed Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
Condition: Sjögren's Syndrome Patients With Severe Dry Eye
Interventions: Drug: 0.02% Fm, SH;   Drug: 0.02% Fm, SH, 0.05% CsA;   Other: 0.02% Fm, SH, tBCL;   Drug: 0.02% Fm, SH, AS
34 Completed Evaluation of FID 114657 in Sjogren's Syndrome Subjects
Condition: Sjogren's Syndrome
Intervention: Other: FID 114657 (ORB Preserved Ocular Emulsion)
35 Completed Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome
Conditions: Sjogren's Syndrome;   Dysautonomia
Intervention:
36 Completed An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness
Conditions: Xerostomia;   Sjogren's Syndrome
Interventions: Drug: P-552;   Drug: Vehicle rinse
37 Completed Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome
Conditions: Xerostomia;   Sjogren's Syndrome
Intervention: Drug: NGX267
38 Recruiting A Study of Flt3-Ligand Levels in Sjögrens Syndrome
Condition: Sjogrens Syndrome
Intervention:
39 Recruiting Primary Sjögren Syndrome
Condition: Primary Sjögren's Syndrome
Intervention: Other: skin biopsy
40 Recruiting Effect of Debridement-scaling on the Relief of Dry Eye Signs and Symptoms in Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Procedure: Lid debridgement scaling

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years